Welcome to our dedicated page for GoodRx Holdings news (Ticker: $GDRX), a resource for investors and traders seeking the latest updates and insights on GoodRx Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GoodRx Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GoodRx Holdings's position in the market.
GoodRx (Nasdaq: GDRX) has entered a new direct contracting agreement with The Kroger Co. to offer enhanced prescription savings at over 2,200 Kroger pharmacy locations nationwide.
Starting June 1, 2024, patients using a GoodRx coupon can expect almost 50% more savings on most generic medications.
This partnership aims to support Kroger's business objectives and improve patients' access to affordable prescriptions.
GoodRx will discuss this agreement during its Investor Day on May 15 at 9 a.m. ET.
GoodRx Holdings, Inc. reported financial results for the first quarter of 2024. Revenue increased by 8% to $197.9 million, with a net loss of $1.0 million. Adjusted EBITDA was $62.8 million. The company focuses on capital allocation, share repurchases, and M&A. GoodRx anticipates revenue growth for the second quarter and full year 2024.